Other News

Kalos Medical Announces Grant Award, Completion of Patient Recruitment of Clinical Trial

SEOUL, South Korea, May 03, 2023 (GLOBE NEWSWIRE) — Kalos Medical, Inc. (“Kalos”), a developer of innovative and minimally invasive medical devices using proprietary catheter-based technology, announced that on April 24th it was selected as a participant in the 2023 Industrial Technology Innovation Project, administered by South Korea’s Ministry of […]

Microbot Medical’s LIBERTY® Robotic System Surpasses 100th Catheterization

95% success rate of reaching pre-determined vascular target with no intraoperative complications presented during pre-clinical studies HINGHAM, Mass., May 03, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY Robotic system, the first fully disposable robotic system, announced the system has surpassed its 100th catheterization […]

Amarin Reports First Quarter 2023 Financial Results and Provides Business Update

— Stable Revenue and Cash Position Due to Performance of U.S. Business and Savings from Operational Initiatives — — Early Progress in Launch of VAZKEPA® (icosapent ethyl) in England & Wales; Pricing & Reimbursement Discussions in Key European Markets Ongoing — — International Strategy Progressing with CSL Seqirus Partnership for Australia […]

Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation

– Transaction values Avertix at an enterprise value of $195 million – Avertix developed the Guardian™ System, the first and only FDA-approved solution designed to detect and warn patients of cardiac events, including silent heart attacks EATONTOWN, N.J. and NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) — Avertix Medical, Inc. (“Avertix” or […]

Thubrikar Aortic Valve to Present Promising Initial Results of CE Mark-Enabling Study With Novel Optimum TAV™ at EuroPCR 2023

NORRISTOWN, Pa.–(BUSINESS WIRE)–Thubrikar Aortic Valve, Inc., is happy to announce that results of the initial CE Mark-enabling study using the Optimum Transcatheter Aortic Valve (Optimum TAV™) in patients with severe aortic stenosis will be presented at the upcoming EuroPCR 2023 Conference. EuroPCR is an annual, world-leading conference on interventional cardiovascular […]

US Heart & Vascular and Rubicon Founders Announce Partnership to Build the Premier Cardiovascular Value-Based Care Model in the United States

Partnership Reinforces USHV’s Position as a Leading Cardiovascular Practice Management Organization and Will Drive Efforts to Transform How Quality Cardiovascular Care Is Delivered NASHVILLE, Tenn.–(BUSINESS WIRE)–US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, announced today that it has entered into an agreement […]